Effectiveness of first-line antiretroviral therapy based on NNRTIs vs ritonavir-boosted PIs in HIV-1 infected patients with high plasma viral load

Vista senzilla d'ítem
dc.contributor.authorImaz, Arkaitz
dc.contributor.authorLlibre, Josep María
dc.contributor.authorNavarro Bernabé, Joan
dc.contributor.authorCurto, J. J. (Jorge Juan)
dc.contributor.authorClotet, Bonaventura, 1953-
dc.contributor.authorCrespo, M.
dc.contributor.authorMurillo Rubio, Óscar
dc.contributor.authorFerrer, Elena
dc.contributor.authorSaumoy, Maria
dc.contributor.authorTiraboschi, Juan Manuel
dc.contributor.authorPodzamczer Palter, Daniel
dc.date.accessioned2018-11-27T11:38:22Z
dc.date.available2018-11-27T11:38:22Z
dc.date.issued2012-11-11
dc.date.updated2018-07-24T12:52:22Z
dc.description.abstractPurpose of the study: few clinical trials have compared non-nucleoside reverse transcriptase inhibitors (NNRTI) and ritonavir-boosted protease inhibitors (PI/r) as initial combined antiretroviral therapy (cART) for HIV-1-infected patients with high plasma viral load (pVL), and non-conclusive results have been reported. We compared the effectiveness between NNRTI and PI/r as first-line cART fof HIV-1-infected patients with high pVL.
dc.format.extent1 p.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/2445/126488
dc.language.isoeng
dc.publisherWiley
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.7448/IAS.15.6.18235
dc.relation.ispartofJournal of the International Aids Society, 2012, vol. 15, num. 18235, p. 147
dc.relation.urihttps://doi.org/10.7448/IAS.15.6.18235
dc.rightscc by (c) Imaz et al., 2012
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationInfeccions per VIH
dc.subject.classificationAntiretrovirals
dc.subject.otherHIV infections
dc.subject.otherAntiretroviral agents
dc.titleEffectiveness of first-line antiretroviral therapy based on NNRTIs vs ritonavir-boosted PIs in HIV-1 infected patients with high plasma viral load
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
ImazA.pdf
Mida:
178.06 KB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))